News & Trends - Pharmaceuticals

Sanofi Australia expands its inclusion and diversity program

Health Industry Hub | June 26, 2020 |
[Total: 1    Average: 5/5]

Sanofi Australia and New Zealand has launched its first Accessibility Inclusion Plan, as the latest step in its broad inclusion and diversity program.

The Plan, which has been lodged with the Australian Human Rights Commission, outlines Sanofi’s committed actions to create an accessible and inclusive environment where all employees feel comfortable to openly share, and ask for, workplace adjustments that help them to perform at their best.

Sanofi Australia and New Zealand’s Chief Financial Officer, Yogita Nath, is executive sponsor for the internal team who led the Accessibility Inclusion Plan’s development.

“Sanofi has a proud history of supporting and empowering people who have a diverse range of individual needs. The addition of our inaugural Accessibility Inclusion Plan is an important part of formalising this commitment to our current and future workforces, and wider community,” she said.

Register-and-join-Health-Industry-Hub-Pharma-MedTech-Biotech

“Now, with so much uncertainty evident across the corporate landscape, there has never been a greater need to invest in work that makes businesses more inclusive.

“We all know that diverse and inclusive businesses exhibit increased profitability and creativity, and better problem solving abilities.
“Building a working environment where we can hear and learn from a diverse range of voices, and welcome diverse points of view always makes good business sense. This need is even more pronounced during challenging periods.”

The Sanofi Australia and New Zealand Accessibility Inclusion Plan outlines seventeen actions across four priority areas: employees, workplace, patients / consumers and our corporate social responsibility.

The seventeen actions include commitments to:

  1. Review all existing recruitment programs to identity and remove any unintended barriers from existing recruitment, selection and onboarding processes
  2. Create and deliver new training and learning programs for all leaders and employees
  3. Create and deliver a new policy and procedure to support Workplace Adjustments where needed
  4. Pilot an internship program for young people living with a disability
  5. Review all existing physical workplaces to ensure they meet accessibility requirements.

Sanofi Australia and New Zealand Director of Human Resources, Michelle Zimany, thanked everyone who had been involved in researching and crafting the Plan.

“This Plan represents a truly collaborative effort having been created in consultation with our working group, key stakeholders and external experts who have provided invaluable insight,” she said.

“Across Australia and New Zealand, 1 in 5 people live with a disability. By taking conscious steps to remove any unintended bias and make our business more accessible, we will open more doors to a wider range of talented future employees.”

Actions within the Sanofi Australia and New Zealand Accessibility Inclusion Plan will be delivered across 2020 and 2021 and will be reviewed annually.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Medical Technology

MedTech News - Private health insurer looking to invest in Australian private hospitals

Private health insurer looking to invest in Australian private hospitals

Health Industry Hub | July 15, 2020 |

MedTech News: In a recent opinion piece Dr Bill Coote, former AMA Secretary General and former Director of the Medicare […]

More


News & Trends - Pharmaceuticals

Pharma News - Merck Australia supports the first Australian-developed COVID-19 vaccine - Sypharma and Vaxine

Merck Australia supports the first Australian-developed COVID-19 vaccine

Health Industry Hub | July 15, 2020 |

Pharma News: Sypharma, an Australian biopharmaceutical formulation company, announced manufacturing of COVAX-19 and Advax adjuvant for Covid-19 in partnership with […]

More


News & Trends - Pharmaceuticals

Pharma News - Precision prescribing to combat Australia’s expected surge in mental illness

Precision prescribing to combat Australia’s expected surge in mental illness

Health Industry Hub | July 15, 2020 |

Pharma News: COVID-19 social isolation, familial and community disconnection, shock, job loss and health fears create the perfect storm for […]

More


Medical

Medical Pharma Biotech MedTech - $47M accelerator program for MedTech, Biotech and Pharma sectors in diabetes and cardiovascular disease

$47M accelerator program for MedTech, Biotech and Pharma sectors in diabetes and cardiovascular disease

Health Industry Hub | July 15, 2020 |

Medical News: The operation of the Australian Government’s $47 million Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular […]

More